AQR CAPITAL MANAGEMENT LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1167557
Greenwich, CT
Position in REGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$951,126,014
+$182,567,341 QoQ
Shares Held
1,231,008
+23.6% QoQ
Ownership
1.17%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 92.24091151316645.ToString("F0")%
Shared 0.ToString("F0")%
None 7.759088486833554.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AQR CAPITAL MANAGEMENT LLC holds $4,606,642,545 across 213 Biotechnology names. REGN ranks #1 (20.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
1,231,008 | $951,126,014 | |
| 2 | EXEL |
Exelixis, Inc.
|
13,095,741 | $561,676,326 | |
| 3 | INCY |
Incyte Corp
|
5,807,930 | $546,642,368 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
7,676,541 | $433,647,798 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
913,104 | $302,118,715 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,338,458 | $253,035,481 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,782,038 | $181,424,357 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,946,858 | $164,727,963 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $951,126,014 | 1,231,008 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $768,558,673 | 995,710 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $405,595,709 | 721,354 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $60,239,550 | 114,742 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $149,646,566 | 235,950 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $147,512,856 | 207,085 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $237,090,361 | 225,534 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $198,950,518 | 189,291 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $175,608,225 | 182,452 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $172,040,323 | 195,881 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $156,501,479 | 190,169 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $157,827,310 | 219,650 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $197,836,772 | 240,774 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $223,052,240 | 309,155 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $296,421,449 | 430,301 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $325,367,409 | 550,416 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $355,342,825 | 508,781 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $283,943,390 | 449,619 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $167,049,650 | 276,033 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $108,420,991 | 194,115 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $137,523,344 | 290,661 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $170,975,043 | 353,905 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $260,355,916 | 465,104 | Shares | Other | 2020-11-16 | |
| 2020-06-30 | $225,650,289 | 361,822 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $188,249,465 | 385,528 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||